550 related articles for article (PubMed ID: 25321423)
1. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
Jackson RD; Mysiw WJ
Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of fracture risk in the Women's Health Initiative.
Jackson RD; Donepudi S; Mysiw WJ
Curr Osteoporos Rep; 2008 Dec; 6(4):155-61. PubMed ID: 19032926
[TBL] [Abstract][Full Text] [Related]
3. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
5. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
6. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
Orwoll ES; Nelson HD
J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
[TBL] [Abstract][Full Text] [Related]
7. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
[TBL] [Abstract][Full Text] [Related]
8. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
Levine JP
Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
[TBL] [Abstract][Full Text] [Related]
10. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
[TBL] [Abstract][Full Text] [Related]
11. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
13. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal osteoporosis: fracture risk and prevention.
Kaunitz AM; McClung MR; Feldman RG; Wysocki S
J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
[TBL] [Abstract][Full Text] [Related]
15. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
Prentice RL; Pettinger MB; Jackson RD; Wactawski-Wende J; Lacroix AZ; Anderson GL; Chlebowski RT; Manson JE; Van Horn L; Vitolins MZ; Datta M; LeBlanc ES; Cauley JA; Rossouw JE
Osteoporos Int; 2013 Feb; 24(2):567-80. PubMed ID: 23208074
[TBL] [Abstract][Full Text] [Related]
16. Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study.
Rouzi AA; Al-Sibiani SA; Al-Senani NS; Radaddi RM; Ardawi MS
Bone; 2012 Mar; 50(3):713-22. PubMed ID: 22178778
[TBL] [Abstract][Full Text] [Related]
17. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
[TBL] [Abstract][Full Text] [Related]
18. Baseline age and time to major fracture in younger postmenopausal women.
Gourlay ML; Overman RA; Fine JP; Ensrud KE; Crandall CJ; Gass ML; Robbins J; Johnson KC; LeBlanc ES; Womack CR; Schousboe JT; LaCroix AZ;
Menopause; 2015 Jun; 22(6):589-97. PubMed ID: 25349960
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis and hip fracture.
Birge SJ
Clin Geriatr Med; 1993 Feb; 9(1):69-86. PubMed ID: 8443741
[TBL] [Abstract][Full Text] [Related]
20. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
